Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II
BACKGROUND:Whether prolonged dual antiplatelet therapy (DAPT) improves clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesion is uncertain. METHODS AND RESULTS:We evaluated 2082 patients who were treated with drug-eluting stent for bifurcation lesions and were eve...
Gespeichert in:
Veröffentlicht in: | Circulation. Cardiovascular interventions 2018-07, Vol.11 (7), p.e005849-e005849 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND:Whether prolonged dual antiplatelet therapy (DAPT) improves clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesion is uncertain.
METHODS AND RESULTS:We evaluated 2082 patients who were treated with drug-eluting stent for bifurcation lesions and were event free (no death, myocardial infarction [MI], cerebrovascular accident, stent thrombosis, or any revascularization) at 12 months after the index procedure. Patients were divided into 2 groupsDAPT ≥12-month group (n=1776) and DAPT |
---|---|
ISSN: | 1941-7640 1941-7632 |
DOI: | 10.1161/CIRCINTERVENTIONS.117.005849 |